Selective targeting of serotonin 5-ht1a and 5-ht3 receptors attenuates acute and long-term hypersensitivity associated with neonatal procedural pain

HIGHLIGHTS

• who: Nynke J. van den Hoogen from the United States University College London have published the research: Selective Targeting of Serotonin 5-HT1a and 5-HT3 Receptors Attenuates Acute and Long-Term Hypersensitivity Associated With Neonatal Procedural Pain, in the Journal: (JOURNAL)
• what: The aim of this study is to prevent the acute and longterm consequences of repetitive neonatal procedural pain by pharmacological targeting the serotonin 5-HT1aR or 5-HT3R in neonates. The authors focus on two serotonin receptors: the inhibitory 5HT1a and the excitatory 5-HT3. The authors show that selective neonatal agonism . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.